Subscribe to our newsletter

Get our monthly newsletter with updates on business and science related activities in Medicon Valley.








Latest news

> PRINT THIS PAGE
   SHARE
Here you will find all news from Medicon Valley

441 events   Page 1 of 45   |   Next page
Jun. 13, 2013
> ExpreS2ion Biotechnologies and Cancer Research UK’s London Research Institute Enter a Licensing Agreement for Use of the ExpreS2 Technology Platform
Jun. 12, 2013
> New enzyme technology saves up to 5% corn in ethanol
New technology allows the biofuels industry to produce more ethanol with less corn while saving energy and improving profits.
Jun. 8, 2013
> PROTEIN BLOCK STOPS VASCULAR DAMAGE IN DIABETES
Researchers at Lund University in Sweden have discovered how to stop the destructive process that leads to cardiovascular disease in diabetic laboratory animals.
Jun. 4, 2013
> Zealand and Helsinn announce Helsinn’s decision to advance the development of elsiglutide into Phase IIb for the prevention of chemotherapy-induced diarrhea
May 23, 2013
> Novo A/S acquires Xellia Pharmaceuticals for US$ 700 million
May 21, 2013
> Novo Nordisk reports positive results from first phase 3 trial with long-acting factor IX for treatment of haemophilia B
May 17, 2013
> POSSIBLE TREATMENT FOR SERIOUS BLOOD CANCER
May 8, 2013
> Novo Nordisk invests DKK 380 million in its Kalundborg plant
May 8, 2013
> Mouse model confirms how type 2 diabetes develops
Researchers at Lund University in Sweden have developed a new mouse model that answers the question of what actually happens in the body when type 2 diabetes develops and how the body responds to drug treatment.
May 6, 2013
> Symphogen Expands Previous Private Equity Round, Reaching a Total of € 141 million (USD 185 Million)